Skip to main content
Top
Published in: Journal of Neurology 8/2022

21-03-2022 | Stroke | Original Communication

Time trends in stroke severity in the years 2005 to 2020: results from the Austrian Stroke Unit Registry

Authors: Alexandra Bernegger, Dominika Mikšová, Alexandra Posekany, Stefan Krebs, Julia Ferrari, Stefan Greisenegger, Thomas Gattringer, Wilfried Lang, Stefan Kiechl, Marek Sykora, the Austrian Stroke Unit Registry Collaborators

Published in: Journal of Neurology | Issue 8/2022

Login to get access

Abstract

Background and purpose

With aging population, there is an increase of atrial fibrillation (AF) and other vascular risk factors. We investigated trends in stroke severity at hospital admission with respect to AF and other risk factors in a prospective national stroke registry from 2005 to 2020.

Methods

Data from the prospective Austrian Stroke Unit Registry were used to study demographic and clinical factors associated with the change in admission stroke severity over years. Time trends in admission stroke severity of patients with pre-stroke modified Rankin Score ≤ 3 were investigated with respect to clinical variables and predefined age groups 18–54, 55–64, 65–74, 75–84 and ≥ 85 years. Time trends were studied using robust generalized linear models assuming normal distribution with a log link. Stroke severity on admission was assessed according to the National Institutes of Health Stroke Scale Score (NIHSS).

Results

In total, 140,312 patients with acute ischemic stroke were included in the analysis. Within the study period, mean patients’ age increased from 70 to 72 years (p < 0.001) and median NIHSS at admission decreased from 4 to 3 (p < 0.001). The frequency of AF increased from 25 to 32% (p < 0.001). The decrease in median admission NIHSS was evident in all relevant subgroups but more pronounced in patients with risk factors including AF, diabetes, hypercholesterolemia, smoking, elderly patients and those with pre-stroke disability.

Conclusion

Despite an aging population and generally increasing AF frequency, we observed a consistent trend towards less disabling strokes on admission.
Literature
1.
go back to reference Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM et al (2004) Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 363(9425):1925–1933CrossRef Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM et al (2004) Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 363(9425):1925–1933CrossRef
2.
go back to reference Lackland DT, Roccella EJ, Deutsch AF, Fornage M, George MG, Howard G et al (2014) Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke 45(1):315–353CrossRef Lackland DT, Roccella EJ, Deutsch AF, Fornage M, George MG, Howard G et al (2014) Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke 45(1):315–353CrossRef
3.
go back to reference Nezu T, Hosomi N, Lip GY, Aoki S, Shimomura R, Maruyama H et al (2016) Temporal trends in stroke severity and prior antithrombotic use among acute ischemic stroke patients in Japan. Circ J 80(9):2033–2036CrossRef Nezu T, Hosomi N, Lip GY, Aoki S, Shimomura R, Maruyama H et al (2016) Temporal trends in stroke severity and prior antithrombotic use among acute ischemic stroke patients in Japan. Circ J 80(9):2033–2036CrossRef
4.
go back to reference Koton S, Geva D, Streifler JY, Harnof S, Pougach Y, Azrilin O et al (2018) Declining rate and severity of hospitalized stroke from 2004 to 2013: the National Acute Stroke Israeli Registry. Stroke 49(6):1348–1354CrossRef Koton S, Geva D, Streifler JY, Harnof S, Pougach Y, Azrilin O et al (2018) Declining rate and severity of hospitalized stroke from 2004 to 2013: the National Acute Stroke Israeli Registry. Stroke 49(6):1348–1354CrossRef
5.
go back to reference Teuschl Y, Brainin M, Matz K, Dachenhausen A, Ferrari J, Seyfang L et al (2013) Time trends in patient characteristics treated on acute stroke-units: results from the Austrian Stroke Unit Registry 2003–2011. Stroke 44(4):1070–1074CrossRef Teuschl Y, Brainin M, Matz K, Dachenhausen A, Ferrari J, Seyfang L et al (2013) Time trends in patient characteristics treated on acute stroke-units: results from the Austrian Stroke Unit Registry 2003–2011. Stroke 44(4):1070–1074CrossRef
6.
go back to reference Hajat C, Heuschmann PU, Coshall C, Padayachee S, Chambers J, Rudd AG et al (2011) Incidence of aetiological subtypes of stroke in a multi-ethnic population based study: the South London Stroke Register. J Neurol Neurosurg Psychiatry 82(5):527–533CrossRef Hajat C, Heuschmann PU, Coshall C, Padayachee S, Chambers J, Rudd AG et al (2011) Incidence of aetiological subtypes of stroke in a multi-ethnic population based study: the South London Stroke Register. J Neurol Neurosurg Psychiatry 82(5):527–533CrossRef
7.
go back to reference Dulli DA, Stanko H, Levine RL (2003) Atrial fibrillation is associated with severe acute ischemic stroke. Neuroepidemiology 22(2):118–123CrossRef Dulli DA, Stanko H, Levine RL (2003) Atrial fibrillation is associated with severe acute ischemic stroke. Neuroepidemiology 22(2):118–123CrossRef
8.
go back to reference Yiin GS, Howard DP, Paul NL, Li L, Mehta Z, Rothwell PM et al (2017) Recent time trends in incidence, outcome and premorbid treatment of atrial fibrillation-related stroke and other embolic vascular events: a population-based study. J Neurol Neurosurg Psychiatry 88(1):12–18CrossRef Yiin GS, Howard DP, Paul NL, Li L, Mehta Z, Rothwell PM et al (2017) Recent time trends in incidence, outcome and premorbid treatment of atrial fibrillation-related stroke and other embolic vascular events: a population-based study. J Neurol Neurosurg Psychiatry 88(1):12–18CrossRef
9.
go back to reference Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY (2010) Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 123(7):638-45e4CrossRef Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY (2010) Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 123(7):638-45e4CrossRef
10.
go back to reference Gladstone DJ, Bui E, Fang J, Laupacis A, Lindsay MP, Tu JV et al (2009) Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke 40(1):235–240CrossRef Gladstone DJ, Bui E, Fang J, Laupacis A, Lindsay MP, Tu JV et al (2009) Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke 40(1):235–240CrossRef
11.
go back to reference Seelig J, Verheugt FWA, Hemels MEW, Illingworth L, Lucassen A, Adriaansen H et al (2020) Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry. Thromb J 18:5CrossRef Seelig J, Verheugt FWA, Hemels MEW, Illingworth L, Lucassen A, Adriaansen H et al (2020) Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry. Thromb J 18:5CrossRef
12.
go back to reference Steinberg BA, Gao H, Shrader P, Pieper K, Thomas L, Camm AJ et al (2017) International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries. Am Heart J 194:132–140CrossRef Steinberg BA, Gao H, Shrader P, Pieper K, Thomas L, Camm AJ et al (2017) International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries. Am Heart J 194:132–140CrossRef
13.
go back to reference Reichardt B. Therapie des Vorhofflimmerns. Konsensus Heilmittelökonomie. 2017.*** Reichardt B. Therapie des Vorhofflimmerns. Konsensus Heilmittelökonomie. 2017.***
14.
go back to reference Steiner MM, Brainin M, Austrian Stroke Registry for Acute Stroke U (2003) The quality of acute stroke units on a nation-wide level: the Austrian Stroke Registry for acute stroke units. Eur J Neurol 10(4):353–360CrossRef Steiner MM, Brainin M, Austrian Stroke Registry for Acute Stroke U (2003) The quality of acute stroke units on a nation-wide level: the Austrian Stroke Registry for acute stroke units. Eur J Neurol 10(4):353–360CrossRef
15.
go back to reference Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20(7):864–870CrossRef Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20(7):864–870CrossRef
16.
go back to reference Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24(1):35–41CrossRef Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24(1):35–41CrossRef
17.
go back to reference Sakamoto Y, Okubo S, Sekine T, Nito C, Suda S, Matsumoto N et al (2018) Prior direct oral anticoagulant therapy is related to small infarct volume and no major artery occlusion in patients with stroke and non-valvular atrial fibrillation. J Am Heart Assoc 7(17):e009507CrossRef Sakamoto Y, Okubo S, Sekine T, Nito C, Suda S, Matsumoto N et al (2018) Prior direct oral anticoagulant therapy is related to small infarct volume and no major artery occlusion in patients with stroke and non-valvular atrial fibrillation. J Am Heart Assoc 7(17):e009507CrossRef
18.
go back to reference Jung YH, Kim YD, Kim J, Han SW, Oh MS, Lee JS et al (2020) Initial stroke severity in patients with atrial fibrillation according to antithrombotic therapy before Ischemic stroke. Stroke 51(9):2733–2741CrossRef Jung YH, Kim YD, Kim J, Han SW, Oh MS, Lee JS et al (2020) Initial stroke severity in patients with atrial fibrillation according to antithrombotic therapy before Ischemic stroke. Stroke 51(9):2733–2741CrossRef
19.
go back to reference Tomita H, Hagii J, Metoki N, Saito S, Shiroto H, Hitomi H et al (2015) Severity and functional outcome of patients with cardioembolic stroke occurring during non-vitamin K antagonist oral anticoagulant treatment. J Stroke Cerebrovasc Dis 24(6):1430–1437CrossRef Tomita H, Hagii J, Metoki N, Saito S, Shiroto H, Hitomi H et al (2015) Severity and functional outcome of patients with cardioembolic stroke occurring during non-vitamin K antagonist oral anticoagulant treatment. J Stroke Cerebrovasc Dis 24(6):1430–1437CrossRef
20.
go back to reference Xian Y, O’Brien EC, Liang L, Xu H, Schwamm LH, Fonarow GC et al (2017) Association of preceding antithrombotic treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation. JAMA 317(10):1057–1067CrossRef Xian Y, O’Brien EC, Liang L, Xu H, Schwamm LH, Fonarow GC et al (2017) Association of preceding antithrombotic treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation. JAMA 317(10):1057–1067CrossRef
21.
go back to reference Hoyer C, Filipov A, Neumaier-Probst E, Szabo K, Ebert A, Alonso A (2018) Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke. J Thromb Thrombolysis 45(4):529–535CrossRef Hoyer C, Filipov A, Neumaier-Probst E, Szabo K, Ebert A, Alonso A (2018) Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke. J Thromb Thrombolysis 45(4):529–535CrossRef
22.
go back to reference Gadsboll K, Staerk L, Fosbol EL, Sindet-Pedersen C, Gundlund A, Lip GYH et al (2017) Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark. Eur Heart J 38(12):899–906PubMed Gadsboll K, Staerk L, Fosbol EL, Sindet-Pedersen C, Gundlund A, Lip GYH et al (2017) Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark. Eur Heart J 38(12):899–906PubMed
23.
go back to reference Camm AJ, Accetta G, Ambrosio G, Atar D, Bassand JP, Berge E et al (2017) Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation. Heart 103(4):307–314CrossRef Camm AJ, Accetta G, Ambrosio G, Atar D, Bassand JP, Berge E et al (2017) Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation. Heart 103(4):307–314CrossRef
24.
go back to reference Suzuki S, Otsuka T, Sagara K, Semba H, Kano H, Matsuno S et al (2016) Nine-year trend of anticoagulation use, thromboembolic events, and major bleeding in patients with non-valvular atrial fibrillation- shinken database analysis. Circ J 80(3):639–649CrossRef Suzuki S, Otsuka T, Sagara K, Semba H, Kano H, Matsuno S et al (2016) Nine-year trend of anticoagulation use, thromboembolic events, and major bleeding in patients with non-valvular atrial fibrillation- shinken database analysis. Circ J 80(3):639–649CrossRef
25.
go back to reference Cowan JC, Wu J, Hall M, Orlowski A, West RM, Gale CP (2018) A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation. Eur Heart J 39(32):2975–2983CrossRef Cowan JC, Wu J, Hall M, Orlowski A, West RM, Gale CP (2018) A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation. Eur Heart J 39(32):2975–2983CrossRef
27.
go back to reference Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383(9921):955–962CrossRef Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383(9921):955–962CrossRef
28.
go back to reference Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22(8):983–988CrossRef Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22(8):983–988CrossRef
29.
go back to reference Bogiatzi C, Hackam DG, McLeod AI, Spence JD (2014) Secular trends in ischemic stroke subtypes and stroke risk factors. Stroke 45(11):3208–3213CrossRef Bogiatzi C, Hackam DG, McLeod AI, Spence JD (2014) Secular trends in ischemic stroke subtypes and stroke risk factors. Stroke 45(11):3208–3213CrossRef
Metadata
Title
Time trends in stroke severity in the years 2005 to 2020: results from the Austrian Stroke Unit Registry
Authors
Alexandra Bernegger
Dominika Mikšová
Alexandra Posekany
Stefan Krebs
Julia Ferrari
Stefan Greisenegger
Thomas Gattringer
Wilfried Lang
Stefan Kiechl
Marek Sykora
the Austrian Stroke Unit Registry Collaborators
Publication date
21-03-2022
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 8/2022
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-022-11079-x

Other articles of this Issue 8/2022

Journal of Neurology 8/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine